My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
RTS Power Corporation schedules board meeting
Aug 21,2017

RTS Power Corporation will hold a meeting of the Board of Directors of the Company on 14 September 2017, to approve the Unaudited Standalone Financial Results of the Company for the Quarter and three months ended on 30th June, 2017

Powered by Capital Market - Live News

Sterling Powergensys to conduct AGM
Aug 21,2017

Sterling Powergensys announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2017.

Powered by Capital Market - Live News

Artillegence Bio-Innovations to conduct AGM
Aug 21,2017

Artillegence Bio-Innovations announced that the Annual General Meeting (AGM) of the company will be held on 11 August 2017.

Powered by Capital Market - Live News

ETP Corporation to convene AGM
Aug 21,2017

ETP Corporation announced that the Annual General Meeting (AGM) of the company will be held on 25 September 2017.

Powered by Capital Market - Live News

Ashiana Agro Industries schedules AGM
Aug 21,2017

Ashiana Agro Industries announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2017.

Powered by Capital Market - Live News

Esquire Money Guarantees to convene AGM
Aug 21,2017

Esquire Money Guarantees announced that the Annual General Meeting (AGM) of the company will be held on 26 September 2017.

Powered by Capital Market - Live News

Stock Net International to conduct AGM
Aug 21,2017

Stock Net International announced that the Annual General Meeting (AGM) of the company will be held on 26 September 2017.

Powered by Capital Market - Live News

Vardhman Polytex to hold AGM
Aug 21,2017

Vardhman Polytex announced that the Annual General Meeting (AGM) of the company will be held on 9 September 2017.

Powered by Capital Market - Live News

Talbros Engineering schedules AGM
Aug 21,2017

Talbros Engineering announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2017.

Powered by Capital Market - Live News

Vimal Oil and Foods to conduct AGM
Aug 21,2017

Vimal Oil and Foods announced that the Annual General Meeting (AGM) of the company will be held on 29 September 2017.

Powered by Capital Market - Live News

Board of Super Crop Safe consider conversion of warrants
Aug 21,2017

Super Crop Safe announced that a Board meeting was held on 21 August, 2017 for the allotment of 3,00,000 Equity Shares of the Company, on Conversion of Convertible Warrants issued on Preferential basis to the Promoter at a price of Rs.70/- per warrant i.e. 08th October, 2016 (Date of Allotment of Convertible Warrants). The Company had also received in-principle approval from the Bombay Stock Exchange for this matter on 05 October, 2016.

Powered by Capital Market - Live News

Max India allots 1,86,268 equity shares
Aug 21,2017

Max India has allotted 1,86,268 equity shares of Rs.2/- each of the Company for cash at par arising from exercise of Stock Options granted by the Company on 19 August 2017.

Powered by Capital Market - Live News

Shivalik Bimetal Controls proposes bonus issue
Aug 21,2017

Shivalik Bimetal Controls proposes bonus issue of shares. The Board of the Company will consider the proposal on 23 August 2017.

Powered by Capital Market - Live News

IVRCL update on divestment of 3 tollway projects
Aug 21,2017

IVRCL announced that the long pending deal with TRIL Roads for sale of three SPVs (Kumarapalayam Tollways, Salem Tollways and IVRCL Chengapally) got terminated due to delay in achieving certain conditions precedent, as per the share purchase agreements.

The Company is exploring other options for disinvestment of these tollway projects in order to reduce the debt burden of these SPV Companies and free the investment of the Company.

Powered by Capital Market - Live News

Jubilant receives NDA approval for Drax Exametazime
Aug 21,2017

Jubilant Life Sciences has announced that Jubilant Pharma, a material wholly owned subsidiary of the Company, through one of its wholly owned subsidiaries, Jubilant Draximage Inc, Montreal, Canada, hasreceived U.S. Food and Drug Administration (USFDA) approval for Drax Exametazime (Kit for the Preparation of Tc99m Exametazime for leukocyte labeling), for its New Drug Application (NDA) pursuant to section 505 (b) (2) filing. This approved new drug application is indicated for leukocyte (white blood cell) labeled scintigraphy as an adjunct in the localization of intraabdominal infection and inflammatory bowel disease.

This is the sixth approval that the Company has received from the USFDA during the current financial year. As on 30 June 2017, Jubilant had a total of 84 ANDAs for Oral Solids filed in the US, of which 53 had been approved and 12 Injectable filings of which 9 had been approved.

Powered by Capital Market - Live News